Adjusted EBITDA was $39 million, or 5.3% of net sales, for the Q1 2024, compared to $47 million, or 5.9% of net sales in the Q1 2023, which includes the net benefit of duty-related items.
BlueLinx
Adjusted EBITDA was $39 million, or 5.3% of net sales, for the Q1 2024, compared to $47 million, or 5.9% of net sales in the Q1 2023, which includes the net benefit of duty-related items.